Showing results (31-40 of 229) with videos related to
Sort By:
Pageof 23
Pneumologie (Stuttgart, Germany)|September 10, 2010
[Tuberculosis - historical development, current status, future prospects]R Loddenkemper, R Diel, T SchabergThe European Respiratory Journal|October 1, 1996
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisT Schaberg, K Rebhan, H LodeBiochemical and Biophysical Research Communications|June 14, 1991
Evidence for a platelet-activating factor receptor on human alveolar macrophagesT Schaberg, H Haller, H LodePneumologie (Stuttgart, Germany)|August 31, 2007
[Emergence extensive drug resistance tuberculosis (XDR)]H Vier, T Schaberg, A GillissenThe European Respiratory Journal|September 2, 2005
Cost-effectiveness of isoniazid chemoprevention in close contactsR Diel, A Nienhaus, T SchabergChest|January 1, 1997
Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?R Erbes, T Schaberg, R LoddenkemperPneumologie (Stuttgart, Germany)|May 14, 2015
[Non Tuberculous Mycobacteria--a Short Review about Epidemiology, Diagnosis and Treatment]L Bös, N Schönfeld, T SchabergTherapeutische Umschau. Revue Therapeutique|November 7, 2001
[Nosocomial pneumonia]S Ewig, P Walger, H VetterThe European Respiratory Journal|April 9, 2001
Severity assessment in community-acquired pneumoniaS Ewig, H Schäfer, A TorresPageof 23